Narayan Prabhu
Board Member
Reviva Pharmaceuticals Holdings, Inc. (RVPH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Narayan Prabhu
Narayan Prabhu is recorded as Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH). The proxy statement of Reviva Pharmaceuticals Holdings, Inc. reports total compensation of $404,950 for Narayan Prabhu in fiscal 2024, including a base salary of $325,000. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Reviva Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Rahul Nayar CEO
- Parag Saxena Chairman, Board Member
- Gonzalo Cordova CFO
- Laxminarayan Bhat Board Member
- Les Funtleyder Board Member
- Purav Patel Board Member
- Richard Margolin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | $325,000 | $404,950 |
| 2023 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | $325,000 | $1,248,778 |
| 2022 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | $275,000 | $412,500 |
| 2021 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | $275,000 | $437,134 |
| 2020 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | $13,573 | $45,304 |
| 2019 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Financial Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.